Many AMI Clients will be directly affected by the upcoming implementation of the Sunshine Act by the Federal Government. In an effort to keep our community informed, we wanted to bring to your attention the missing of a critical deadline by the Centers for Medicare and Medicaid Services to draft regulations for the Physician Payment Sunshine Act. In response to this delay, Andy McNeill, CEO of American Meetings, Inc. (AMI), states, “While many clients are taking voluntary steps to address their reporting requirements some are waiting on direct guidance from the Federal Government. There is no indication that requirements will be postponed by this delay and AMI recommends all of its clients in the Pharmaceutical, Biotech and Device fields to continue with an aggressive implementation of systems to address these areas.”
The Sunshine Act requires manufacturers to report all payments to physicians, including consulting fees, honoraria, travel and entertainment, and for the Department of Health and Human Services (HHS) to publicly disclose the identity of the manufacturer, physician, and the drug or device associated with the payment on the internet. Additionally, the law requires manufacturers and group purchasing organizations (GPOs) to report all ownership or investment interests held by physicians or members of their family, and for making that information public. The law required HHS to establish guidance on how manufacturers submit information and how the information would be made available to the public no later than October 1, 2011.
CLICK HERE To read the letter written by U.S. Senators Chuck Grassley (R-Iowa) and Herb Kohl (D-Wis.)
To read the article CLICK HERE